Publication: 2434

Publication: 2434

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 34 (22) 2602-2609

Year:: 2016
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 5

Parents:: 2267
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Roche/Genentech, Novartis
Grants:: U10CA180821, U10CA180882, U10CA180863, U10 CA031946, U10 CA033601, U10 CA180821, U10 CA180858, U10 CA180795, P30 CA008748, U10 CA180791, U10 CA180882, U10 CA180820, U10 CA180867, U10 CA180838, U10 CA180888, U10 CA138561

Corr. Author:
Authors:: Maura N. Dickler William T. Barry Constance T. Cirrincione Matthew J. Ellis Mary Ellen Moynahan Federico Innocenti Arti Hurria Hope S. Rugo Diana E. Lake Olwen Hahn Bryan P. Schneider Debasish Tripathy Lisa A. Carey Eric P. Winer Clifford A. Hudis

Networks:: CA824, LAPS-CT018, LAPS-IL057, LAPS-NC007, LAPS-NY016, LAPS-TX035, NY018, TX041

Study: CALGB-40503
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Bc7, ORIGINAL REPORTS, Breast Cancer